AKT1 and prostate carcinoma: For example, constitutive activation of PI3K/AKT signaling increases intracellular cholesterol levels through SREBP-1 activation, resulting in de novo cholesterol biosynthesis and LDL receptor (LDLR) expression, thereby enhancing exogenous cholesterol import in prostate cancer (Guo et al., 2011).